Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Monica Hazra; Hiroyuki Uchida; Beth Sproule; Gary Remington; Takefumi Suzuki; David C. Mamo

doi:10.1111/j.1440-1819.2011.02280.x

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Monica Hazra, Hiroyuki Uchida, Beth Sproule, Gary Remington, Takefumi Suzuki, David C. Mamo

Department of Psychiatry

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Abstract

The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

Original language	English
Pages (from-to)	676-678
Number of pages	3
Journal	Psychiatry and Clinical Neurosciences
Volume	65
Issue number	7
DOIs	https://doi.org/10.1111/j.1440-1819.2011.02280.x
Publication status	Published - 2011 Dec

Keywords

antipsychotic
monitoring
polypharmacy
prescription
schizophrenia

ASJC Scopus subject areas

Neuroscience(all)
Neurology
Clinical Neurology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1440-1819.2011.02280.x

Cite this

@article{232d0f60759d470ba4914b06caa2901b,

title = "Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia",

abstract = "The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.",

keywords = "antipsychotic, monitoring, polypharmacy, prescription, schizophrenia",

author = "Monica Hazra and Hiroyuki Uchida and Beth Sproule and Gary Remington and Takefumi Suzuki and Mamo, {David C.}",

year = "2011",

month = dec,

doi = "10.1111/j.1440-1819.2011.02280.x",

language = "English",

volume = "65",

pages = "676--678",

journal = "Psychiatry and Clinical Neurosciences",

issn = "1323-1316",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

AU - Hazra, Monica

AU - Uchida, Hiroyuki

AU - Sproule, Beth

AU - Remington, Gary

AU - Suzuki, Takefumi

AU - Mamo, David C.

PY - 2011/12

Y1 - 2011/12

N2 - The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

AB - The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy.

KW - antipsychotic

KW - monitoring

KW - polypharmacy

KW - prescription

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84255190969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255190969&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2011.02280.x

DO - 10.1111/j.1440-1819.2011.02280.x

M3 - Article

C2 - 22176287

AN - SCOPUS:84255190969

SN - 1323-1316

VL - 65

SP - 676

EP - 678

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

IS - 7

ER -

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this